Proteomic Characterization of the Angiogenesis Inhibitor SU6668 Reveals Multiple Impacts on Cellular Kinase Signaling

Klaus Godl(Phenex Pharmaceuticals (Germany)), Henrik Daub(Max Planck Institute of Biochemistry)
Cancer Research
August 1, 2005
Cited by 104


Related Papers